Physician profile
Brian G Sollers
NPI 1386934461
$8,929.00
in general payments reported to CMS, 2019-2025
20 companies · $7,097 in 2025
The $7,097 reported for 2025 was more than what 98% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156 · 2020: $112 · 2021: $300 · 2022: $1,017 · 2023: $109 · 2024: $139 · 2025: $7,097.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Travel and Lodging: $2,489 · Food and Beverage: $855.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Travel and Lodging | $2,489.27 |
| Food and Beverage | $855.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,965.21 | 2025 | |
| Applied Medical Resources Corporation | $702.85 | 2022 | |
| Hologic Sales and Service, LLC | $248.44 | 2021-2024 | Acessa Provu System, Coolseal Generator, Novasure |
| Abbvie INC. | $191.21 | 2019-2021 | |
| Astellas Pharma US INC | $140.13 | 2022-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $119.66 | 2019-2022 | |
| Exeltis, USA INC. | $77.75 | 2020-2024 | Slynd |
| Ethicon US, LLC | $69.72 | 2021-2022 | |
| Mimedx Group, INC. | $65.82 | 2024-2025 | |
| Axonics, INC. | $50.22 | 2022-2024 | Bulkamid |
| Amag Pharmaceuticals, INC. | $49.26 | 2019-2020 | |
| Organon LLC | $47.95 | 2022-2023 | Nexplanon |
| Merck Sharp & Dohme LLC | $37.56 | 2020-2021 | |
| Dysis Medical, INC. | $28.59 | 2022 | |
| Minerva Surgical, INC | $27.52 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $23.35 | 2025 | Zurzuvae |
| Supernus Pharmaceuticals, INC. | $23.35 | 2025 | Qelbree |
| Daiichi Sankyo INC. | $22.26 | 2022 | |
| Therapeuticsmd, INC. | $19.33 | 2022 | |
| Myovant Sciences INC. | $18.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Sollers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.